Point72 Asset Management, L.P. - CORVUS PHARMACEUTICALS INC ownership

CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 54 filers reported holding CORVUS PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Point72 Asset Management, L.P. ownership history of CORVUS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$1,222,000
-36.2%
745,000
-6.3%
0.01%
-37.5%
Q4 2021$1,916,000
-31.2%
795,000
+38.3%
0.01%
-33.3%
Q3 2021$2,783,000
-10.5%
575,000
+194.8%
0.01%
-14.3%
Q3 2017$3,109,000
+10.6%
195,034
-16.1%
0.01%
-12.5%
Q2 2017$2,812,000
-66.8%
232,383
-43.1%
0.02%
-66.0%
Q1 2017$8,480,000408,2770.05%
Other shareholders
CORVUS PHARMACEUTICALS INC shareholders Q3 2017
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 3,101,709$7,475,0001.50%
ADAMS STREET PARTNERS LLC 3,275,616$7,894,0001.20%
Telemetry Investments, L.L.C. 192,909$465,0000.60%
CHI Advisors LLC 400,000$964,0000.32%
Orbimed Advisors 6,943,654$16,734,0000.22%
Ikarian Capital, LLC 482,610$1,163,0000.17%
Anson Funds Management LP 528,358$1,273,0000.12%
BVF INC/IL 1,370,947$3,304,0000.12%
VR Adviser, LLC 250,000$603,0000.08%
PURA VIDA INVESTMENTS, LLC 492,384$1,187,0000.04%
View complete list of CORVUS PHARMACEUTICALS INC shareholders